Funding the next scientific breakthrough for the world’s poor

June 12, 2012

At the Sabin Vaccine Institute, advocacy is big part of our business. We encourage politicians, philanthropists and the general public to expand immunization programs for vaccine-preventable diseases and increase treatment for over one billion people suffering from neglected tropical diseases.

But we’re also one of the few NGOs that is leading the research and development of vaccines to prevent diseases of poverty.

Sabin

The latest in the series of SIF briefings for parliamentarians in Sierra Leone took place 6th June in the Hotel Bintumani Complex in Aberdeen, just outside Freetown.

 Over the past year, there have been serious typhoid outbreaks in Indonesia, the Philippines and India. These outbreaks are in addition to the endemic typhoid burden found in throughout Southeast Asia.

During June-July, Sabin’s Sustainable Immunization Financing Program is organizing a series of legislative workshops that will take place both at sub-regional (country clusters), national and subnational levels. Eleven SIF countries are participating.

Today, the Rwandan Ministry of Health announced that they will introduce a new rotavirus vaccine nationwide.

Today, representatives at the Sixty-fifth World Health Assembly gave their support to a new Global Vaccine Action Plan (GVAP). WHA endorsement of the GVAP marks a major milestone towards universal access to immunization.

Statement by Bill Gates on the Occasion of the World Health Assembly Resolutions Declaring Completion of Polio Eradication a Global Emergency and Endorsing the Global Vaccine Action Plan

SEATTLE -- “Today marks a huge victory in the fight to protect all children from vaccine-preventable diseases, no matter where they live."

Sabin

Pages

Subscribe to RSS - Vaccine Advocacy and Education